<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">ABC</journal-id><journal-title-group><journal-title>Advances in Biological Chemistry</journal-title></journal-title-group><issn pub-type="epub">2162-2183</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/abc.2015.53013</article-id><article-id pub-id-type="publisher-id">ABC-56009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Chemistry&amp;Materials Science</subject></subj-group></article-categories><title-group><article-title>
 
 
  Interaction of Hemoglobin with Binuclearcationic Tetranitrosyl Iron Complex with Penicillamine. Cations Binding Sites
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>idia</surname><given-names>Syrtsova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Natalia</surname><given-names>Sanina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Boris</surname><given-names>Psikha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Ildar</surname><given-names>Tukhvatullin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Natal’ja</surname><given-names>Shkondina</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Olesia</surname><given-names>Pokidova</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Alexander</surname><given-names>Kotelnikov</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Institute of Problems of Chemical Physics of the Russian Academy of Sciences, Moscow Region, 
Russian Federation</addr-line></aff><pub-date pub-type="epub"><day>28</day><month>04</month><year>2015</year></pub-date><volume>05</volume><issue>03</issue><fpage>169</fpage><lpage>178</lpage><history><date date-type="received"><day>7</day>	<month>December</month>	<year>2014</year></date><date date-type="rev-recd"><day>accepted</day>	<month>22</month>	<year>April</year>	</date><date date-type="accepted"><day>28</day>	<month>April</month>	<year>2015</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  In this paper, the kinetics of the interaction of the nitrosyl iron complex with the ligands penicillamine [Fe
  <sub>2</sub>(SC
  <sub>5</sub>H
  <sub>11</sub>NО
  <sub>2</sub>)
  <sub>2</sub>(NO)
  <sub>4</sub>]SO
  <sub>4</sub>&amp;middot;5H
  <sub>2</sub>O (
  I) with deoxyhemoglobin (Hb) was studied. The kinetic modeling method defined the number of binding (I) molecules and equilibrium constant of the coupling reaction of (Biomedicine, Iron-Sulfur Cluster, Ligand Binding, Heme, Nitric Oxide ) with Hb (K
  <sub>s</sub>). At equimolar concentrations of (I) and Hb (2 &#215; 10
  <sup>&amp;minus;5</sup> M), the Hb molecule binds only one (
  I) with K
  <sub>s</sub> equal to 4.3 &#215; 10
  <sup>7</sup> M
  <sup>&amp;minus;1</sup>. When increasing the (Biomedicine, Iron-Sulfur Cluster, Ligand Binding, Heme, Nitric Oxide ) concentration, the number of binding sites of Hb increases and Ks decreases. These results are analyzed in accordance with the data on the existence of cations binding sites in Hb.
 
</p></abstract><kwd-group><kwd>Biomedicine</kwd><kwd> Iron-Sulfur Cluster</kwd><kwd> Ligand Binding</kwd><kwd> Heme</kwd><kwd> Nitric Oxide</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>In the last ten years, it has been well established that nitric oxide, NO, having a wide spectrum of biological activities and the ability to affect various body systems [<xref ref-type="bibr" rid="scirp.56009-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.56009-ref2">2</xref>] , is actively involved in the process of carcinogenesis [<xref ref-type="bibr" rid="scirp.56009-ref3">3</xref>] . Depending on the chemical characteristics and the local concentration in vivo, NO may act on different biotargets to stimulate the tumor generation process or vice versa, exercising its inhibition [<xref ref-type="bibr" rid="scirp.56009-ref4">4</xref>] -[<xref ref-type="bibr" rid="scirp.56009-ref6">6</xref>] . In this regard, the development of experimental approaches to treatment of neoplastic diseases that are based on NO-therapy requires fundamental study correlations, investigating the “Structure-Activity” of exogenous compounds generating NO in physiological solutions, in order to establish the molecular and genetic mechanisms of their action on target mammalian cells and for the synthesis of compounds with improved properties (low toxicity, greater bioavailability, etc.). Biomimetics of nitrosyl cell intermediates, in particular, synthetic models of the active centers of nitrosyl iron-sulfur proteins, are promising compounds for the treatment of neoplastic diseases [<xref ref-type="bibr" rid="scirp.56009-ref7">7</xref>] . We have previously shown, for the first time, that the anionic and neutral nitrosyl iron complexes (NICs), in the absence of additional activation, decompose with release of NO in protic media containing Hb [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.56009-ref9">9</xref>] , and that the reaction rate constants depend on the molecular structure of the complexes. It was found that the NICs nitrosylated Hb, interacting with the heme at the 6th free coordination site. The resulting complex, HbNO, is a depot of NO. It not only provides a storage form of NO (since the lifetime of free NO in the cell is seconds), but also determines the prolonged action of the NICs as donors of NO. It was also found that NIC nitrosylated not only Hb but also ferri- and ferrocytochrome [<xref ref-type="bibr" rid="scirp.56009-ref10">10</xref>] . It is known [<xref ref-type="bibr" rid="scirp.56009-ref11">11</xref>] that there is a center in Hb for binding of anions formed by positively charged functional amino acid residues that can bind, for example, diphosphoglycerate (DPG). As a result of allosteric binding, DPG affects Hb affinity for O<sub>2</sub>. Recently, we have identified the binding sites of cations in Hb [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] . It was found that a cationic NIC (<xref ref-type="fig" rid="fig1">Figure 1</xref>) with cysteamine ligands (II) [Fe<sub>2</sub>(S(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙2.5H<sub>2</sub>O (CCDC 663194), was a promising anticancer NO-donor agent, apoptosis inducer in human tumor cells [<xref ref-type="bibr" rid="scirp.56009-ref13">13</xref>] , bound with two negatively charged cavities on the Hb surface. These issues are important for the metabolism of cationic NICs and also for investigating the first discovered sites of cation binding in such a physiologically relevant protein as Hb. So, we determined the goal of this work to be the investigation of the binding of Hb with other cationic complex, (I) (<xref ref-type="fig" rid="fig1">Figure 1</xref>) with larger size than (II), in order to reliably verify the existence of cations binding sites in Hb. According to the X-ray diffraction data, the com- plex (I) contains two protonated NH<sub>3</sub>-groups in the penicillamine ligands: [Fe<sub>2</sub>(SC<sub>5</sub>H<sub>11</sub>NО<sub>2</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙5H<sub>2</sub>O (CCDC 680286).</p></sec><sec id="s2"><title>2. Experimental</title><sec id="s2_1"><title>2.1. Materials</title><p>We used bovine Hb (Serva, Germany), Na<sub>2</sub>HPO<sub>4</sub>∙6H<sub>2</sub>O and NaH<sub>2</sub>PO<sub>4</sub>∙H<sub>2</sub>O (MP Biomedicals, Germany). The water was purified by distillation in a Bi/Duplex distiller (Germany). (II) was synthesized using the known method [<xref ref-type="bibr" rid="scirp.56009-ref14">14</xref>] . Synthesis of (I) is described in [<xref ref-type="bibr" rid="scirp.56009-ref15">15</xref>] . It has been obtained by reaction of dissolved in water ferrous</p><fig id="fig1"  position="float"><label><xref ref-type="fig" rid="fig1">Figure 1</xref></label><caption><title> Chemical structures of the tetranitrosyl iron complexes (I) and (II) [<xref ref-type="bibr" rid="scirp.56009-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.56009-ref15">15</xref>] </title></caption><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x5.png"/></fig><p>sulphate (II) with an aqueous solution of D-penicillamine in the molar ratio 1:3. The reaction was per- formed using standard vacuum line and Schlenk technology under argon. Previously, oxygen has been removed from the water by triple freezing and vacuum pumping. To the dry mixture, containing 0.42 g (1.5 mmol) of FeSO<sub>4</sub>∙7H<sub>2</sub>O and 0.68 g (4.5 mmol) D-penicillamine poured 10 ml water, prepared as described above, and nitric oxide have been passed through the resulting deep purple solution at room temperature. The fine red needles have been appeared on the walls of the reaction vessel after 10 - 12 min, gradually filling the entire volume of the solution. The mixture was kept 3 days at 6˚C - 8˚C, filtered and dried in vacuum under argon. The filtered product is stable in the solid phase in the air for a long time (months). Yield is 198 mg (20%). Elemental analysis of the polycrystalline powders obtained was performed at the Analytical Center of the Institute of Problems of Chemical Physics of the Russian Academy of Sciences. For (I): Fe<sub>2</sub>S<sub>3</sub>N<sub>6</sub>C<sub>10</sub>H<sub>32</sub>O<sub>17</sub>. Found %: Fe, 15.62; S, 13.34; N, 11.89; C, 16.80, H, 4.62. Calculated, %: Fe, 15.64; S, 13.42; N, 11.72; C, 16.76, О, 37.99; H, 4.47; IR: ν/cm<sup>−</sup><sup>1</sup> = 1771 (s, NO); 1723 (s, NO).</p></sec><sec id="s2_2"><title>2.2. Operation Technique in Inert Gas Atmosphere</title><p>Operation technique in inert gas atmosphere has been described earlier [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] .</p></sec><sec id="s2_3"><title>2.3. Preparation of Hb Solution</title><p>A homogeneous solution of bovine Hb was prepared from commercial Hb (a mixture of oxygenated hemoglobin (HbO<sub>2</sub>) and methemoglobin according to a known procedure [<xref ref-type="bibr" rid="scirp.56009-ref9">9</xref>] .</p></sec><sec id="s2_4"><title>2.4. Kinetics of Hb Reaction with the Complex (I)</title><p>To a weighed sample of the (I) in a vessel filled with nitrogen, an anaerobic 0.05 M phosphate buffer, pH 7.0, was added so as to prepare a solution of the complex with a concentration of 6 &#215; 10<sup>−4</sup> M. Then the solution was stirred for 15 min under a nitrogen stream until the complex was completely dissolved. An aliquot (0.1: 0.5; 0.75; 1 ml) of the solution was drawn under a nitrogen stream and transferred to the anaerobic sample cell and the reference cell (the volume 4 ml, the optical path length 1 cm) containing an anaerobic phosphate buffer, pH 7.0 in an amount sufficient for obtaining the final (I) concentration 2 &#215; 10<sup>−5</sup>; 10<sup>−4</sup>; 1.5 &#215; 10<sup>−4</sup> and 2 &#215; 10<sup>−4</sup> M, respectively. Then the phosphate buffer, pH 7.0, was added to the reference and sample cells in amounts required to make the volume of the reaction solution after the insertion of Hb into the sample cell equal to 3.0 ml. The reaction was initiated by adding an Hb solution with the initial concentration of 4.5 &#215; 10<sup>−4</sup> M into the sample cell. The concentration of Hb in the sample cell was (1.94 - 2.1) &#215; 10<sup>−5</sup> M. Then the difference absorption spectra were recorded at certain time intervals. The absorption spectra were measured until Hb was completely transformed into HbNO, i.e., until the spectra stopped to change.</p></sec><sec id="s2_5"><title>2.5. Absorption Spectra</title><p>Absorption spectra were recorded at 25˚С using a Specord M-40 spectrophotometer equipped with an interface for computer-aided registration of spectra and thermostatic cuvette holder. Amount of Hb and HbNO was evaluated spectrophotometrically. For this purpose absorption spectra were factored by components using program Mathcad 11 Enterprise Edition as described in the paper [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] .</p></sec><sec id="s2_6"><title>2.6. For Kinetic Modeling</title><p>We considered the assumed reaction scheme describing the interaction of (I) with Hb. The rate constants were determined by the least squares method based on the numerical solution of the corresponding system of differential equations. The concentrations of NO or the HbNO were determined after the resolution of the absorption spectra into components (the spectra of Hb and HbNO), and used as experimental data.</p></sec><sec id="s2_7"><title>2.7. The Analysis of Hb Surface</title><p>The analysis of Hb surface was performed using the program PyMOL [<xref ref-type="bibr" rid="scirp.56009-ref16">16</xref>] . To view and analyze the surface of Hb, we used X-ray data of bovine Hb [<xref ref-type="bibr" rid="scirp.56009-ref17">17</xref>] , retrieved from the database PDB, access code 1HDA (see Ref. [<xref ref-type="bibr" rid="scirp.56009-ref18">18</xref>] ). This method allowed us to determine the total electrostatic surface charge. The density of the color depends on its magnitude. Dimensions can be determined with an accuracy of ~10%.</p></sec></sec><sec id="s3"><title>3. Results and Discussion</title><sec id="s3_1"><title>3.1. Reaction of (I) with Hb</title><p>In the present work we studied the interaction of (I) with Hb. All reactions with complex (I) were carried out under nitrogen because NO rapidly reacts with O<sub>2</sub> to give nitrogen oxides (the rate constant is 2 &#215; 10<sup>6</sup> M<sup>−2</sup>∙s<sup>−1</sup>) [<xref ref-type="bibr" rid="scirp.56009-ref19">19</xref>] . Hb is a trap for NO: the binding rate is close to the diffusion rate [<xref ref-type="bibr" rid="scirp.56009-ref20">20</xref>] , the equilibrium constant is 3 &#215; 10<sup>10</sup> M<sup>−1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref21">21</xref>] . Hb gives a characteristic absorption spectrum, which changes in the course of NO binding. Hence, as was reported in [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.56009-ref9">9</xref>] , the NO release can be followed from the formation of HbNO. Since all sulfur-nitrosyl iron complexes show absorption in the visible region, we recorded the difference absorption spectra of the control and test systems with Hb containing the complex (I) at the same concentrations (see the Experimental section). The changes in the difference absorption spectra with time in the course of the reaction of Hb with the complex (I) are displayed in <xref ref-type="fig" rid="fig2">Figure 2</xref>. We stopped recording the spectra after the latter ceased to change. This was accompanied by a decrease in the absorbance at the maximum at 556 nm in the absorption spectrum of Hb and an increase in the absorbance at 545 and 575 nm suggesting the formation of the HbNO complex. These</p><fig-group id="fig2"><label><xref ref-type="fig" rid="fig2">Figure 2</xref></label><caption><title> Kinetics of change of difference spectra at the interaction of (I): 2 &#215; 10<sup>−</sup><sup>5</sup> (a), 10<sup>−</sup><sup>4</sup> (b), 1.5 &#215; 10<sup>−</sup><sup>4</sup> (c) 2 &#215; 10<sup>−</sup><sup>4</sup> (d) M with Hb 2 &#215; 10<sup>−</sup><sup>5</sup> (a), 1.96 &#215; 10<sup>−</sup><sup>5</sup> (b) 2.1 &#215; 10<sup>−</sup><sup>5</sup> (c), 1.94 &#215; 10<sup>−</sup><sup>5</sup> (d) M. λ = 450 - 650 nm. Solvent is 0.05 M phosphate buffer, pH 7.0, temperature is 25˚С. Dotted lines are the spectrum of Hb. Spectra 1-8 were registered at 0.16, 0.33, 0.5, 0.66, 0.91, 1.16, 2.16, 3.16 (a), 0.03, 0.07, 0.1, 0.15, 0,33, 1, 2.25, 3.16 (c), spectra 1-7 were registered at 0.03, 0.07, 0.12, 0.27, 0.42, 0.67, 3.83 (b), and 0.05, 0.1, 0.15, 0.25, 1.35, 1.83, 3.92 (d) h after start of reaction. Conditions of reaction: 25˚С, solvent is 0.05 M phosphate buffer, pH 7.0.</title></caption><fig id ="fig2_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x6.png"/></fig><fig id ="fig2_2"><label>(c)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x7.png"/></fig><fig id ="fig2_3"><label> (d)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x8.png"/></fig><fig id ="fig2_4"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x9.png"/></fig></fig-group><p>spectra have three isosbestic points at 551, 570, and 595 nm. This is evidence that only Hb and HbNO contribute to the absorption spectra, as in the case of the reactions of this class of NICs with Hb investigated in our earlier research [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] . We measured the kinetics of the formation of HbNO by recording the accumulation of HbNO and the deconvolution of the absorption spectra with the use of the MathCad program (<xref ref-type="fig" rid="fig3">Figure 3</xref>). The rate constants k (<xref ref-type="table" rid="table1">Table 1</xref>) is somewhat less than the constant rate of NO release from (I), defined by the sensor electrode in 0.05 M phosphate buffer pH 7.0 and a temperature 25˚C in a nitrogen atmosphere: k<sub>1</sub> = (4.6 &#177; 0.1) &#215; 10<sup>−3</sup> s<sup>−1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref22">22</xref>] . In [<xref ref-type="bibr" rid="scirp.56009-ref8">8</xref>] the authors explain why the HbNO formation reaction should “track” the NO released from NIC. We firmly established that Hb usually stabilizes the NIC and the reaction of NO release in the presence of Hb is slower than without Hb, as was found in the determination of the reaction rate of NO release from NIC using the sensor electrode [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] . We have determined that sulfur ligands, which are part of the NICs with excess electron density, contribute to the stabilization of complexes in solution [<xref ref-type="bibr" rid="scirp.56009-ref9">9</xref>] . The greater the electron density on the NIC ligand, the more stable it is in the presence of Hb [<xref ref-type="bibr" rid="scirp.56009-ref23">23</xref>] . This stabilization is due to a known anion-binding center in Hb, located in the cavity between Hb subunits [<xref ref-type="bibr" rid="scirp.56009-ref11">11</xref>] . Recently, we described the presence of cations binding sites on Hb. In the case of the cationic NIC (II), having thiol ligands cysteamine instead of penicillamines there was significant stabilization of the complex in the presence of Hb. This was attributed to the presence of the cationic sites, negative charge centers, reversible binding (II), and that these centers were visualized [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] . The size of (I) was greater than the size of (II). Thus, using the program PyMOL [<xref ref-type="bibr" rid="scirp.56009-ref16">16</xref>] , we found that the size of the (I) dication is ~375 &#197;<sup>3</sup>, while the size of the (II) dication is equal to ~265 &#197;<sup>3</sup> [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] .</p></sec><sec id="s3_2"><title>3.2. Kinetic Modeling of the Reactions of (I) with Hb</title><p>Consider the reaction of (I) with Hb. If Hb is present in the medium, it seems, due to the large value of the equilibrium constant of<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x10.png" xlink:type="simple"/></inline-formula>, equal to 3 &#215; 10<sup>10</sup> М<sup>−1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref21">21</xref>] , it shifts the equilibrium decomposition reaction of (I) towards the formation of HbNO and, being a depot for NO, carries it to the respective targets.</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> The values of the kinetic parameters K<sub>s</sub> and n<sub>s</sub>, describing the interaction of the complex (I) with Hb</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >No</th><th align="center" valign="middle" >[(I)]0∙105, М</th><th align="center" valign="middle" >[Hb]0∙105, М</th><th align="center" valign="middle" >ns</th><th align="center" valign="middle" >Ks∙10<sup>−7</sup>, М<sup>−1 </sup></th></tr></thead><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.0</td><td align="center" valign="middle" >1.0</td><td align="center" valign="middle" >4.3</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1.96</td><td align="center" valign="middle" >5.0</td><td align="center" valign="middle" >0.80</td></tr><tr><td align="center" valign="middle" >3</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >2.10</td><td align="center" valign="middle" >7.0</td><td align="center" valign="middle" >0.71</td></tr><tr><td align="center" valign="middle" >4</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >1.94</td><td align="center" valign="middle" >10.2</td><td align="center" valign="middle" >0.64</td></tr></tbody></table></table-wrap><fig-group id="fig3"><label><xref ref-type="fig" rid="fig3">Figure 3</xref></label><caption><title> Kinetics of HbNO formation upon interaction of (I) (a) 2 &#215; 10<sup>−</sup><sup>5</sup> and (b): 10<sup>−</sup><sup>4</sup> (2), 1.5 &#215; 10<sup>−</sup><sup>4</sup> (1) and 2 &#215; 10<sup>−</sup><sup>4</sup> (3) M with Hb: [Hb]<sub>0</sub> (a) 2.0 &#215; 10<sup>5</sup>, and (b): 1.96 &#215; 10<sup>5</sup> (1), 2.1 &#215; 10<sup>5</sup> (2), 1.94 &#215; 10<sup>5</sup> (3) M. Points are the experimental data, the lines are calculation on the basis of the reactions of <xref ref-type="fig" rid="fig2">Figure 2</xref>. Kinetic curve 2 in (b) is based on data in <xref ref-type="fig" rid="fig2">Figure 2</xref>(b); the curve 1, <xref ref-type="fig" rid="fig2">Figure 2</xref>; curve 3, <xref ref-type="fig" rid="fig2">Figure 2</xref>(d).</title></caption><fig id ="fig3_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x11.png"/></fig><fig id ="fig3_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x12.png"/></fig></fig-group><p>Without the Hb equilibrium decomposition reaction of (I), evidently biased toward (I) decomposition. It is consumed in the reactions of NO, known as the universal controllers necessary for functions of cellular metabolism [<xref ref-type="bibr" rid="scirp.56009-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.56009-ref2">2</xref>] .</p><p>In [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] , the authors observed a decrease in the processing rate for NO release for cysteamine cationic NIC (II) in the presence of Hb, which was explained by adsorption of the complex by the Hb molecule, resulting in a substantially reduced capacity of (II) to evolve NO. For (I), a structural analog of (II), the reaction scheme corresponds to a model of the given process:</p><disp-formula id="scirp.56009-formula18"><label>(1)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x13.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula19"><label>(2)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x14.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula20"><label>(3)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x15.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula21"><label>(4)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x16.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula22"><label>(5)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x17.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula23"><label>(6)</label><graphic position="anchor" xlink:href="http://html.scirp.org/file/1-1350282x18.png"  xlink:type="simple"/></disp-formula><p>Here S<sub>Hb</sub> are the active binding site of (I) on Hb surface.</p><p>In accordance with this scheme, the free molecules of complex (II) evolve NO in solution, with reversible reaction rate constants k<sub>1</sub> and k<sub>−</sub><sub>1</sub>. Decomposition of (I) in water is followed by separation of the penicillamine ligand [<xref ref-type="bibr" rid="scirp.56009-ref22">22</xref>] from molecule (I) and the product P<sub>1</sub>, which is obtained after the separation of NO from (I), as seen in reactions (2) and (3). Simultaneously, the molecule is (I) adsorbed on an Hb macromolecule. It is assumed that the binding sites of (I) exist on Hb surface (in a certain amount, n<sub>s</sub> per Hb molecule), with which the molecule of complex (I) can reversibly interact with an equilibrium constant, K<sub>s</sub>. In the bound state of the complex, molecules evolve NO with a rate constant of k<sub>4</sub>. The separated NO molecules reversibly interact with the heme iron of Hb to form the experimentally measured HbNO product.</p><p>He values of rate constants k<sub>1</sub> = 4.6 &#215; 10<sup>−</sup><sup>3</sup> s<sup>−</sup><sup>1</sup>, k<sub>−</sub><sub>1</sub> = 9.7 &#215; 10<sup>3</sup> M<sup>−</sup><sup>1</sup>∙s<sup>−</sup><sup>1</sup>, k<sub>2</sub> = 5.3 &#215; 10<sup>−</sup><sup>4</sup> s<sup>−</sup><sup>1</sup>, k<sub>−</sub><sub>2</sub> = 0.1 M<sup>−</sup><sup>1</sup>∙s<sup>−</sup><sup>1</sup>, k<sub>3</sub> = 6.6 &#215; 10<sup>−</sup><sup>6</sup> s<sup>−</sup><sup>1</sup> we determined in paper [<xref ref-type="bibr" rid="scirp.56009-ref22">22</xref>] . The literature contains information on the value of the constant k<sub>5</sub> = 10<sup>8</sup> s<sup>−</sup><sup>1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref19">19</xref>] and the equilibrium constant K<sub>5</sub>, k<sub>5</sub>/k<sub>−</sub><sub>5</sub>, equal to 3 &#215; 10<sup>10</sup> M<sup>−</sup><sup>1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref21">21</xref>] . The unknown parameters are K<sub>s</sub>, n<sub>s</sub> and k<sub>4</sub>. Analysis of the inverse problem has shown that by available experimental data, these parameters cannot be uniquely determined. Therefore, in a first approximation, we considered the limiting case when NO release by the bound complex (I)―S<sub>Hb</sub> is negligible. This regime corresponds to the value of k<sub>4</sub> ~ 10<sup>−</sup><sup>8</sup> s<sup>−</sup><sup>1</sup> [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] , as in the case of (II). The problem reduces to the determination with the experimental data [HbNO](t), the equilibrium constant K<sub>s</sub>, and the number of active sites on the surface of the hemoglobin, n<sub>s</sub>.</p><p>The corresponding system of equations is as follows:</p><disp-formula id="scirp.56009-formula24"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x19.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula25"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x20.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula26"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x21.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula27"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x22.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula28"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x23.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula29"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x24.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula30"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x25.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula31"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x26.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula32"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x27.png"  xlink:type="simple"/></disp-formula><disp-formula id="scirp.56009-formula33"><graphic  xlink:href="http://html.scirp.org/file/1-1350282x28.png"  xlink:type="simple"/></disp-formula><p>Here<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x29.png" xlink:type="simple"/></inline-formula>;<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x29.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x30.png" xlink:type="simple"/></inline-formula>.</p><p>The initial conditions, taking into account the detailed balance in the reaction (4):</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x31.png" xlink:type="simple"/></inline-formula>,</p><p>where</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x32.png" xlink:type="simple"/></inline-formula>;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x33.png" xlink:type="simple"/></inline-formula>;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x34.png" xlink:type="simple"/></inline-formula>;</p><p><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x35.png" xlink:type="simple"/></inline-formula>;</p><p>Here<inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x36.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x36.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x37.png" xlink:type="simple"/></inline-formula>, <inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x36.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x37.png" xlink:type="simple"/></inline-formula><inline-formula><inline-graphic xlink:href="http://html.scirp.org/file/1-1350282x38.png" xlink:type="simple"/></inline-formula>are the initial concentrations of the complex (I), Hb, and the active sites on the surface S<sub>Hb</sub>, respectively.</p><p>Unknown kinetic parameters K<sub>s</sub> and n<sub>s</sub> were determined by numerical solution of the inverse task, using the kinetics of accumulation of HbNO in four experiments of the (I) interaction with Hb (<xref ref-type="table" rid="table1">Table 1</xref>).</p><p>Calculations were carried out at the value of the equilibrium constant K<sub>5</sub> = 0.5 &#215; 10<sup>9</sup> М<sup>−</sup><sup>1</sup>, which provides a better match of theory and experiment than K<sub>5</sub> = 3 &#215; 10<sup>10</sup> M<sup>−</sup><sup>1</sup>. This is justified, considering the fact that, in the presence of salts, K<sub>5</sub> decreases, wherein the salt effect increases in the following order: NaCl, KCl, sodium citrate, sodium phosphate [<xref ref-type="bibr" rid="scirp.56009-ref24">24</xref>] . In our case, the experiments were performed in 0.05 M phosphate buffer, pH 7.0. Point values (<xref ref-type="table" rid="table1">Table 1</xref>) satisfactorily describe the experimental data (<xref ref-type="fig" rid="fig3">Figure 3</xref>). As seen from <xref ref-type="table" rid="table1">Table 1</xref>, increasing the concentration of the complex causes value n<sub>s</sub> to increase and K<sub>s</sub> to decrease. Apparently, there are various regions of different binding strength on the surface of Hb for binding of the cation complex. At low concentrations of complex (I) (number 1 in <xref ref-type="table" rid="table1">Table 1</xref>), its molecules primarily bind with regions, providing a stronger link (large K<sub>s</sub>), and while increasing the concentration of [(I)]<sub>0</sub> during adsorption, they begin to participate in other regions on the Hb surface with lower bond strength. In processing of the experimental data, this leads to a change in the effective values of the parameters: increase of n<sub>s</sub> and decrease of K<sub>s</sub>.</p></sec><sec id="s3_3"><title>3.3. Possible Location of (I) on the Surface of Hb. Cation Binding Sites</title><p>It is known that Hb is composed of four subunits: two α (A, C) and two β (B, D). The α subunit consists of 141 amino acid residues, and the β subunit contains 145 residues. The α subunits are in contact with each other and form a narrow entrance of the through-channel. The β subunits are in contact with each α subunit, but are not in contact with each other and form a wide entrance of this channel. On the whole, Hb is a symmetrical macromolecule with a twofold symmetry axis and a channel running through the structure. It is known that the anion binding site, where DPG is bound, is located in this through-channel [<xref ref-type="bibr" rid="scirp.56009-ref11">11</xref>] . In the through-channel, 8 cationic and 3 anionic pairs of amino acids were located [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] ; in general it is positively charged and directly enters the channel, which is also positively charged. Therefore, the complexes (I) and (II) can not penetrate to this channel. It has been shown in [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] , using the program PyMOL, that the surface area of Hb has a local concentration of both negatively and positively charged amino acids , as well as more or less than the neutral portion of the surface. Among various roughnesses on the Hb surface, there are four large cavities (see <xref ref-type="fig" rid="fig4">Figure 4</xref>). Two of them (cavities 1) are located in the region of the negatively charged surface from the side of the wide entrance at equal distances (~13 &#197;) from the hemes of the А and D subunits. The volume of the cavity 1 is ~17 &#197;<sup>3</sup>. Two other large cavities (cavities 2) with volumes of ~850 &#197;<sup>3</sup> are also negatively charged and are located symmetrically with respect to the cavity 1 at equal distances from the hemes of the А and D subunits (see <xref ref-type="fig" rid="fig4">Figure 4</xref>). The negative potential of the cavities 1 and the adjacent surfaces is formed by the negatively charged carboxyl groups of the following amino acids: cavity 1 (subunits A, B, D), by A-Glu23, A-Glu27, A-Glu30, A-Asp47, B-Glu5, B-Glu6, B-Glu120, B-Asp128, D-Glu89, D-Asp93, and the terminal aminoacid D-His145; cavity 1 (subunits C, D, B), by C-Glu23, C-Glu27, C-Glu30, C-Asp47, D-Glu5, D-Glu6, D-Glu120, D-Asp128, B-Glu89, B-Asp93 and the terminal amino acid B-His145. The negative potential of the cavities 2 and the adjacent surfaces is formed by the negatively charged carboxyl groups of the following amino acids: cavity 2 (subunits A, C, D), by A-Asp85 and the terminal amino acid A-Arg141, C-Asp6, D-Glu42, D-Asp46, D-Asp51; cavity 2 (subunits C, A, B), by C-Asp85 and the terminal amino acid C-Arg141, A-Asp6, B-Glu42, B-Asp46, B-Asp51. Most likely, the complex (II) can be located in these cavities and can be bound to the negatively charged functional groups of Hb. Correspondingly, it can be suggested that at least one (II) molecule can be bound in the cavity 1, and at least three (II) molecules can be bound in the cavity 2. In total, each Hb molecule can bind at least eight (II) molecules. Taking into account the results of the kinetic modeling [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] , which gave approximately 12 (II)-binding sites per Hb molecule, it can be concluded that there are from 8 to 12 such sites. <xref ref-type="fig" rid="fig4">Figure 4</xref> shows that, in addition to the cavities 1 and 2, there are adjacent surfaces bearing a negative charge. Apparently, they are also involved in the binding of (II). The surfaces in the direct vicinity of the hemes are positively charged, the charge gradually decreasing with increasing distance from the heme. In this study, we had a different situation. The volume of (I) is ~375 &#197;<sup>3</sup>, and only one molecule of (I) can fit into the large, negatively charged cavity, i.e., to cavity 2. Moreover, in this case, the binding is stronger: K<sub>s</sub> = 4.3 &#215; 10<sup>7</sup> M<sup>−</sup><sup>1</sup>. Therefore, the (I) molecules bind more weakly. The PyMOL program identifies shallow and indistinct regions with mixed charge from a small positive to a negative charge on the surface of the β-subunit at a distance of approximately 10 &#197; from the heme. On such areas, the binding of (I) probably occurs in this case, starting from a negative area. So K<sub>s</sub> decreases with increasing concentrations of (I).</p></sec></sec><sec id="s4"><title>4. Conclusion</title><p>The results of this work on the interaction of the complex (I) with Hb fully confirm and complement the findings of [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] of cations binding sites on the Hb surface. The function of these sites in metabolism in general has not yet been established. However, it is clear in the case of NICs. That negative cavities on the surface of Hb are the pools of NICs. Associated with Hb molecules NICs emit NO slightly (k ~ 10<sup>−</sup><sup>8</sup> s<sup>−</sup><sup>1</sup>). Hb may carry adsorbed</p><fig-group id="fig4"><label><xref ref-type="fig" rid="fig4">Figure 4</xref></label><caption><title> Analysis of the Hb surface. The regions with a negative surface charge are shown in red (b) or gtey (a), and the regions with a positive surface charge are shown in blue (b) or black (a). The X-ray diffraction data for the bovine Hb molecule [<xref ref-type="bibr" rid="scirp.56009-ref25">25</xref>] are used. (a) The view on to the through-channel (indicated by an arrow); (b) The view onto the cavities 1 and 2. <xref ref-type="fig" rid="fig4">Figure 4</xref> was taken from paper [<xref ref-type="bibr" rid="scirp.56009-ref12">12</xref>] .</title></caption><fig id ="fig4_1"><label> (b)</label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x39.png"/></fig><fig id ="fig4_2"><label></label><graphic mimetype="image"   position="float"  xlink:type="simple"  xlink:href="http://html.scirp.org/file/1-1350282x40.png"/></fig></fig-group><p>therein NICs to other targets. Since NICs associated with Hb reversibly, under decreasing NICs concentration lose contact with it. We can assume that the binding sites of cations can also be carriers of other metabolites with positively charged functional groups.</p></sec><sec id="s5"><title>Acknowledgements</title><p>This study was financially supported by the RFBR (Grant No. 13-03-00549).</p><p>We wish to thank Dr. A.V. Chudinov for the preparation of program of computer processing of absorption spectra by the least square method using program MathCad.</p></sec><sec id="s6"><title>Supplementary Material</title><p>CCDC 680286 contains the supplementary crystallographic data for complex (I) [Fe<sub>2</sub>(SC<sub>5</sub>H<sub>11</sub>NО<sub>2</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙5H<sub>2</sub>O.</p><p>CCDC 663194 contains the supplementary crystallographic data for complex (II) [Fe<sub>2</sub>(S(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙2.5H<sub>2</sub>O. These data can be obtained free of charge from Cambridge Crystallographic Data Centre via http://www.ccdc.cam.ac.uk/conts/retrieving.html</p></sec><sec id="s7"><title>Abbreviations</title><p>(I) complex [Fe<sub>2</sub>(SC<sub>5</sub>H<sub>11</sub>NО<sub>2</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙5H<sub>2</sub>O</p><p>(II) complex [Fe<sub>2</sub>(S(CH<sub>2</sub>)<sub>2</sub>NH<sub>3</sub>)<sub>2</sub>(NO)<sub>4</sub>]SO<sub>4</sub>∙2.5H<sub>2</sub>O</p><p>NIC nitrosyl iron complex</p><p>Hb deoxyhemoglobin</p></sec></body><back><ref-list><title>References</title><ref id="scirp.56009-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Lancaster, J.R. (2010) Metal-Catalyzed Nitric Oxide Nitrozo Interconversions and Biological Signaling. Nitric Oxide: Biology and Chemistry, 22, 13.</mixed-citation></ref><ref id="scirp.56009-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Lewandowska, H., Kalinowska, M., Brzoska, K., Wojciuk, K., Wojciuk, G. and Kruszewski, M. (2011) Nitrosyl Iron Complexes—Synthesis, Structure and Biology. Dalton Transactions, 40, 8273-8289.http://dx.doi.org/10.1039/c0dt01244k</mixed-citation></ref><ref id="scirp.56009-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Mocellin, S. (2009) Nitric Oxide: Cancer Target or Anti-cancer Agent? Current Cancer Drug Targets, 9, 214-236.http://dx.doi.org/10.2174/156800909787581015</mixed-citation></ref><ref id="scirp.56009-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Wink, D.A. and Mitchell, J.B. (1998) Chemical Biology of Nitric Oxide: Insights into Regulatory, Cytotoxic, and Cytoprotective Mechanisms of Nitric Oxide. Free Radical Biology Medicine, 25, 434-456.http://dx.doi.org/10.1016/S0891-5849(98)00092-6</mixed-citation></ref><ref id="scirp.56009-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Morbidelli, L., Donnini, S. and Ziche, M. (2004) Role of Nitric Oxide in Tumor Angiogenesis. Cancer Treatment and Research, 117, 155-167. http://dx.doi.org/10.1007/978-1-4419-8871-3_11</mixed-citation></ref><ref id="scirp.56009-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Prostovit, L.M., Adams, M.A., Lash, G.E., Heaton, J.P. and Graham, C.H. (2002) Oxygen-Mediated Regulation of Tumor Cell Invasiveness. Involvement of a Nitric Oxide Signaling Pathway. Journal of Biological Chemistry, 277, 35730-35737. http://dx.doi.org/10.1074/jbc.M204529200</mixed-citation></ref><ref id="scirp.56009-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.А. and Аldoshin, S.М. (2011) Structure and Properties of Iron Nitrosyl Complexes with Functionalized Sulfur-Containing Ligands. Russian Chemical Bulletin, International Edition, 60, 1223-1251.http://dx.doi.org/10.1007/s11172-011-0192-x</mixed-citation></ref><ref id="scirp.56009-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.A., Syrtsova, L.A., Shkondina, N.I., Rudneva, T.N., Malkova, E.S., Bazanov, T.A., Kotel’nikov, A.I. and Aldoshin, S.M. (2007) Reaction of Sulfur-Nitrosyl Iron Complexes of “g = 2.03” Family with Hemoglobin (Hb): Kinetics of Hb-NO Formation in Aqueous Solutions. Nitric Oxide: Biology and Chemistry, 16, 181-188.http://dx.doi.org/10.1016/j.niox.2006.10.005</mixed-citation></ref><ref id="scirp.56009-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.A., Syrtsova, L.A., Shkondina, N.I., Malkova, E.S., Kotelnikov, A.I. and Aldoshin, S.M. (2007) Hemoglobin-Stabilized Tetranitrosyl Binuclear Iron Complex with Pyridine-2-yl in Aqueus Solutions. Russian Chemical Bulletin, International Edition, 56, 761-766. http://dx.doi.org/10.1007/s11172-007-0114-0</mixed-citation></ref><ref id="scirp.56009-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Roudneva, T.N., Syrtsova, L.A., Sanina, N.A., Shkondina, N.I., Kotelnikov, A.I. and Aldoshin, S.M. (2010) Formation of Iron Nitrosyl Complexes of Ferri- and Ferrocytochrome C at Its Interaction with Nitrosyl Iron Complex Cysaconite. Nitric Oxide: Biology and Chemistry, 22, 546.</mixed-citation></ref><ref id="scirp.56009-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Arnone, A. (1972) X-Ray Diffraction Study of Binding of 2,3-Diphosphoglycerate to Human Deoxyhaemoglobin. Nature, 237, 146-149. http://dx.doi.org/10.1038/237146a0</mixed-citation></ref><ref id="scirp.56009-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.A., Syrtsova, L.A., Psikha, B.L., Tukhvatullin, I.A., Shkondina, N.I., Rudneva, T.N., Kotel’nikov, A.I. and Aldoshin, S.M. (2012) Revealing of the Cation-Binding Sites on the Surface of Hemoglobin in Its Reaction with the NO Donor, the Nitrosyl Iron Complex {Fe2[S(CH2)2NH3]2(NO)4}SO4&amp;middot;2.5H2O. Russian Chemical Bulletin, 61, 2350-2355. http://dx.doi.org/10.1007/s11172-012-0330-0</mixed-citation></ref><ref id="scirp.56009-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.A., Lysenko, K.A., Zhukova, O.S., Roudneva, T.N., Emel’yanova, N.S. and Aldoshin, S.M. (2011) Water-Soluble Binuclear Nitrosyl Iron Complexes with Natural Aliphatic Thiolyls Possessing Cytotoxic, Apoptotic and NO Donor Activity. Patent No. US 8, 067, 628 B2.</mixed-citation></ref><ref id="scirp.56009-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Roudneva, T.N., Sanina, N.A., Lyssenko, K.A., Aldoshin, S.M., Antipin, M.Y. and Ovanesyan, N.S. (2009) Synthesis and Structure of a Water-Soluble Nitrosyl Iron Complex with Cysteamine Ligand. Mendeleev Communications, 19, 253-255. http://dx.doi.org/10.1016/j.mencom.2009.09.006</mixed-citation></ref><ref id="scirp.56009-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Sanina, N.A., Serebryakova, L.I., Shul’zhenko, N.S., Pisarenko, O.I., Roudeva, T.N. and Aldosin, S.M. (2012) Application of Iron Binuclear Complex Sulphur-Nitrosyl Complex of the Canionic Type as a Vasodilative Drug. Patent No. RU No 2460531 C1.</mixed-citation></ref><ref id="scirp.56009-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">De Lano, W.L. (2002) The PyMOL Molecular Graphics System. Version 0.99rc6 Schr&amp;ouml;dinger, LLC, De Lano Scientific, San Carlos.</mixed-citation></ref><ref id="scirp.56009-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Perutz, M.F., Fermi, G., Poyart, C., Pagnier, J. and Kister, J. (1993) A Novel Allosteric Mechanism in Haemoglobin. Structure of Bovine Deoxyhaemoglobin, Absence of Specific Chloride-Binding Sites and Origin of the Chloride-Linked Bohr Effect in Bovine and Human Haemoglobin. Journal of Molecular Biology, 233, 536-545.http://dx.doi.org/10.1006/jmbi.1993.1530</mixed-citation></ref><ref id="scirp.56009-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Bernstein, F.C., Koetzle, T.F., Williams, G.J.B., Meyer Jr., E.F., Brice, M.D., Rodgers, J.R., Kennard, O., Shimanouchi, T. and Tasumi, M. (1977) The Protein Data Bank: A Computer-Based Archival File for Macromolecular Structures. Journal of Molecular Biology, 112, 535-542. http://dx.doi.org/10.1016/S0022-2836(77)80200-3</mixed-citation></ref><ref id="scirp.56009-ref19"><label>19</label><mixed-citation publication-type="book" xlink:type="simple">Miles, A.M., Wink, D.A., Cook, J.C. and Grisham, M.B. (1996) Determination of Nitric Oxide Using Fluorescence Spectroscopy. In: Packer, L., Ed., Methods in Enzymology V, Part A, Academic Press, New York, 105-121.</mixed-citation></ref><ref id="scirp.56009-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Cassoly, R. and Gibson, Q.H. (1975) Conformation, Co-Operativity and Ligand Binding in Human Hemoglobin. Journal of Molecular Biology, 91, 301-313. http://dx.doi.org/10.1016/0022-2836(75)90382-4</mixed-citation></ref><ref id="scirp.56009-ref21"><label>21</label><mixed-citation publication-type="book" xlink:type="simple">Antonini, E. and Brunori, M. (1971) Hemoglobin and Myoglobin in the Reactions with Ligands. In: Neuberger, A. and Tatum, E.L., Eds., North-Holland Research Monographs. Frontiers of Biology, Vol. 21, North-Holland Publishing Company, Amsterdam and London, 276.</mixed-citation></ref><ref id="scirp.56009-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Syrtsova, L.A., Sanina, N.A., Lyssenko, K.A., Kabachkov, E.N., Psikha, B.L., Shkondina, N.I., Pokidova, O.V., Kotelnikov, A.I. and Aldoshin, S.M. (2014) Reversible Dissociation and Ligand-Glutathione Exchange Reaction in Binuclear Cationic Tetranitrosyl Iron Complex with Penicillamine. Bioinorganic Chemistry and Applications, 2014, Article ID: 641407. http://dx.doi.org/10.1155/2014/641407</mixed-citation></ref><ref id="scirp.56009-ref23"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sanina</surname><given-names> N.A. Syrtsova</given-names></name>,<name name-style="western"><surname> L.A.</surname><given-names> Chudinova</given-names></name>,<name name-style="western"><surname> E.S.</surname><given-names> Shkondina</given-names></name>,<name name-style="western"><surname> N.I.</surname><given-names> Rudneva</given-names></name>,<name name-style="western"><surname> T.N.</surname><given-names> Kotelrnikov</given-names></name>,<name name-style="western"><surname> A.I. and Aldoshin</surname><given-names> S.M. </given-names></name>,<etal>et al</etal>. (<year>2009</year>)<article-title>Regularities in the Stabilization by Hemoglobin of Binuclear Iron Complexes [Fe2(μ-N-C-SR)2(NO)4] Containing Benzimidazolyl and Benzothiazolylthiol Ligands</article-title><source> Russian Chemical Bulletin</source><volume> 58</volume>,<fpage> 566</fpage>-<lpage>571</lpage>.<pub-id pub-id-type="doi"></pub-id></mixed-citation></ref><ref id="scirp.56009-ref24"><label>24</label><mixed-citation publication-type="book" xlink:type="simple">Haurowitz, F. and Hardin, R. (1954) Respiratory Proteins. In: Neurath, H. and Bailey, K., Eds., The Proteins, Academic Press, New York, 279-344.</mixed-citation></ref><ref id="scirp.56009-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Perutz, M.F., Shih, D.T. and Williamson, D. (1994) The Chloride Effect in Human Hemoglobin: A New Kind of Allosteric Mechanism. Journal of Molecular Biology, 239, 555-560. http://dx.doi.org/10.1006/jmbi.1994.1394</mixed-citation></ref></ref-list></back></article>